Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Inflammatory demyelinating neuropathy heralding accelerated Chediak-Higashi syndrome.
Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Astrocyte Dysfunction in Developmental Neurometabolic Diseases.
[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential].
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
[Influence of manganese exposure via intracerebral injection on behavioristics and substantia nigra dopaminergic neurons in rats].
Fatigue in Multiple Sclerosis: Misconceptions and Future Research Directions.
Myelinating glia differentiation is regulated by extracellular matrix elasticity.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
WAIS-IV GAI and CPI discrepancies in multiple sclerosis and traumatic brain injury.
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Immunohistochemical and transcriptome analyses indicate complex breakdown of axonal transport mechanisms in canine distemper leukoencephalitis.
Immediate effect of two yoga-based relaxation techniques on cognitive functions in patients suffering from relapsing remitting multiple sclerosis: A comparative study.
Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
Factitious Graves' disease due to biotin immunoassay interference - A case and review of the literature.
B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression.
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.

Pages